Pharma MarMEX:PHM1N 86 Median PS Value is MXN1,658.83 as of Jun. 26, 2026, which is 100% below its 10-year median of 1.25. GuruFocus rates MEX:PHM1N with a GF Score™ of 86/100 and a GF Value™ of MXN1,937.69. The stock has 3 warning signs investors should review. Among 277 Biotechnology companies, Pharma Mar ranks worse than 74.37% on this metric.
This valuation method assumes that the stock valuation will revert to its historical (10-Year) median in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
Median PS Value is calculated as trailing twelve months (TTM) Revenue per Share times 10-Year median PS Ratio. Pharma Mar's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was MXN322.501. Pharma Mar's 10-Year median PS Ratio is 5.1436. Therefore, the Median PS Value for today is MXN1,658.83.
As of today (2026-06-26), Pharma Mar's share price is MXN1608.38. Pharma Mar's Median PS Value is MXN1,658.83. Therefore, Pharma Mar's Price to Median PS Value for today is 0.97.
The historical rank and industry rank for Pharma Mar's Median PS Value or its related term are showing as below:
MEX:PHM1N'
s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.64 Med: 1.25 Max: 2.72
Current: 0.97
During the past 13 years, the highest Price to Median PS Value of Pharma Mar was 2.72. The lowest was 0.64. And the median was 1.25.
MEX:PHM1N's Price-to-Median-PS-Value is ranked worse than 74.37% of 277
companies
in the Biotechnology industry
Industry Median: 0.63
vs MEX:PHM1N: 0.97
Pharma Mar (MEX:PHM1N) Median PS Value Explanation
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio
is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.
Pharma Mar's Price to Median PS Value for today is calculated as
Price to Median PS Value
=
Share Price
/
Median PS Value
=
1608.38
/
1,658.83
=
0.97
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Pharma Mar Median PS Value Related Terms
Pharma Mar Median PS Value Historical Data
* Premium members only.
The historical data trend for Pharma Mar's Median PS Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MEX:PHM1N vs VRTX, REGN, ALNY: Median PS Value Comparison
For the Biotechnology subindustry, Pharma Mar's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Pharma Mar Price-to-Median-PS-Value vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Pharma Mar's Price-to-Median-PS-Value distribution charts can be found below:
* The bar in red indicates where Pharma Mar's Price-to-Median-PS-Value falls into.
10-Year Median PS Ratio is 5.1436.
Pharma Mar's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN322.501.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Pharma Mar (MEX:PHM1N) has a Median PS Value of MXN1,658.83 as of Jun. 26, 2026. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Pharma Mar and its competitors. This is 132606% above median its historical median of 1.25. Over the past decade, Pharma Mar's Median PS Value has ranged from 0.64 to 2.72. According to the industry distribution chart, Pharma Mar ranks #206 out of 277 companies in the Biotechnology industry, placing it in the top 74.4%.
Is Pharma Mar's Median PS Value too high?
Pharma Mar's current Median PS Value of MXN1,658.83 is 132606% above median its 10-year median of 1.25. Over the past 10 years, this metric has ranged from a low of 0.64 to a high of 2.72. Based on the distribution chart, Pharma Mar ranks #206 out of 277 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Pharma Mar has a GF Score™ of 86/100, reflecting its overall financial health beyond just this single metric.
How does Pharma Mar's Median PS Value compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Pharma Mar ranks #206 out of 277 companies for Median PS Value. This places Pharma Mar in the lower half of its industry. The industry median Median PS Value is 0.63. Historically, Pharma Mar's own Median PS Value has ranged from 0.64 to 2.72 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Median PS Value for a Biotechnology company?
The median Median PS Value among Biotechnology companies is 0.63, based on 277 companies in the industry. Companies in the top quartile (top 25%) have a Median PS Value significantly above this median, while those in the bottom quartile fall well below. However, Median PS Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Median PS Value mean?
A high Median PS Value can signal that a stock is expensive relative to its fundamentals. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Pharma Mar and its competitors. For the Biotechnology industry, the median Median PS Value is 0.63 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Pharma Mar's current Median PS Value is MXN1,658.83, which is 132606% above median its own 10-year median of 1.25. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pharma Mar stock overvalued right now?
Pharma Mar (MEX:PHM1N) has a current Median PS Value of MXN1,658.83. The stock's GF Value™ is MXN1,937.69, compared to a current price of MXN1,608.38 — trading 17% below its estimated fair value. The current Median PS Value is MXN1,658.83, which is 132606% above median its 10-year median of 1.25. Pharma Mar's overall GF Score™ is 86/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Median PS Value calculated?
Median PS Value is calculated from a company's financial statements. For Pharma Mar (MEX:PHM1N), the current Median PS Value is MXN1,658.83 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Pharma Mar (MEX:PHM1N) Overvalued in 2026?
Based on GuruFocus' analysis, Pharma Mar stock appears to be undervalued.
The current stock price of MXN1,608.38 is trading 17% below its estimated GF Value™ of MXN1,937.69.
Key valuation signals for MEX:PHM1N:
Median PS Value: MXN1,658.83 (132606% above median its 10-year median of 1.25)
GF Value™: MXN1,937.69 vs. price of MXN1,608.38 (17% below fair value)
No single metric tells the full story. See the MEX:PHM1N stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Pharma Mar SA is engaged in the research, development, production, and commercialization of bio-active principles of marine origin for application in oncology. It also produces and markets insecticides and air fresheners for household use, household products, wood treatment and decoration products, paints, and similar products. Its operating business segments are Oncology and RNAi. The company obtains its revenues from two main areas: biopharmaceuticals and consumer chemicals, but the biopharmaceuticals is the main line of business.
86GF Score
Get the complete analysis for MEX:PHM1N
Median PS Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:PHM1N has been successfully added to your 
